Evidence map›Paper›PMID 32083985›Full record

ReviewRadiology2020

Coronavirus Disease 2019 (COVID-19): A Perspective from China.

Zi Yue Zu, Meng Di Jiang, Peng Peng Xu, Wen Chen, Qian Qian Ni, Guang Ming Lu, Long Jiang Zhang

8 registry-linked trialsAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 828 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
828citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04316728 naunknown statusnot on this map

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in a Cohort of Negative Patients for Coronavirus Infection for the Early Detection of Positive Antibodies for COVID-19

TypeinterventionalSponsorCentro Studi Internazionali, ItalyRan2020 to 2020Enrolled200ConditionsCoronavirus InfectionsArmsVivaDiag™ COVID-19 lgM/IgG Rapid Test
NCT04343768 phase2completednot on this map

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

TypeinterventionalSponsorShahid Beheshti University of Medical SciencesRan2020 to 2020Enrolled60ConditionsCOVID-19ArmsHydroxychloroquine, Lopinavir / Ritonavir, Interferon Beta-1A, Interferon Beta-1B
NCT04353141 unknown statusnot on this map

A Prospective International Lung UltraSound Analysis (ILUSA) Study in Tertiary Maternity Wards During the SARS-CoV-2 Pandemic

TypeobservationalSponsorKU LeuvenRan2020 to 2020Enrolled1,850ConditionsCOVID, Pregnancy Complications, Infectious, Pregnancy Related, Pregnancy, High RiskArmsstandardized Lung Ultrasound (LUS) examination
NCT04359095 phase2 / phase3completednot on this map

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia: A Pragmatic Randomized Controlled Trial

TypeinterventionalSponsorUniversidad Nacional de ColombiaRan2020 to 2021Enrolled650ConditionsCOVID-19ArmsEmtricitabine/tenofovir, Colchicine Pill, Rosuvastatin, Standard treatment
NCT04497311 unknown statusnot on this map

Pulmonary Tomographic Findings in COVID-19 and Influenza H1N1 Patients

TypeobservationalSponsorUniversidad de GuanajuatoRan2020 to 2022Enrolled100ConditionsSARS-CoV-2, Covid19, H1N1 Influenza, Computed TomographyArmsThoraxic computed tomography
NCT04499378 unknown statusnot on this map

Pulmonary Tomographic Findings in COVID-19 and Influenza H1N1 Patients at IMSS Guanajuato

TypeobservationalSponsorUniversidad de GuanajuatoRan2020 to 2022Enrolled200ConditionsCovid19, Influenza A H1N1, Intubation Complication, MoralityArmsLung CT
NCT04516811 phase3terminatednot on this map

A Prospective, Randomized, Placebo-controlled, Double-blinded, Phase III Clinical Trial of the Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

TypeinterventionalSponsorSouth African National Blood ServiceRan2020 to 2022Enrolled102ConditionsCOVID-19, SARS-CoV-2 Infection, Severe Acute Respiratory Syndrome Coronavirus 2ArmsCOVID-19 convalescent plasma (CCP) plus standard of care (SOC), Standard of care (SOC) plus placebo
NCT05859919 phase2completednot on this map

Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of the Viral Disease COVID-19

TypeinterventionalSponsorResearch Institute of Virology, Ministry of Health of the Republic of UzbekistanRan2020 to 2021Enrolled57ConditionsPatients With COVID-19ArmsThe drug "Rutan 0.1"., Basic treatment
3 · Its place in the literature

Who cites it

828 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trends and outcomes ofMicrobiology spectrum · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Artificial intelligence algorithms based approach in evaluating COVID-19 patients and management.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Creatine Kinase as a Predictor of Disease Severity in Children with COVID-19.Medical journal of the Islamic Republic of Iran · 2025
    Article
  20. Article

768 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zi Yue Zu *From the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).
Meng Di Jiang *From the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).
Peng Peng XuFrom the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).
Wen ChenFrom the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).
Qian Qian NiFrom the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).ORCID 0000-0003-4230-5059
Guang Ming LuFrom the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).ORCID 0000-0003-4913-2314
Long Jiang ZhangFrom the Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (Z.Y.Z., M.D.J., P.P.X., Q.Q.N., G.M.L., L.J.Z.); and Department of Medical Imaging, Taihe Hospital, Shiyan, Hubei, China (W.C.).ORCID 0000-0002-6664-7224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond. On February 12, 2020, the World Health Organization officially named the disease caused by the novel coronavirus as coronavirus disease 2019 (COVID-19). Because most patients infected with COVID-19 had pneumonia and characteristic CT imaging patterns, radiologic examinations have become vital in early diagnosis and the assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19 while highlighting the role of chest CT in prevention and disease control.

Indexed as

BetacoronavirusChinaClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingDiagnosis, DifferentialEarly DiagnosisHumansPandemicsPneumonia, ViralSARS-CoV-2Severity of Illness IndexTomography, X-Ray Computed

Identifiers

PMID32083985
PMCPMC7233368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.